SEC 13F Intelligence

Atle Fund Management AB / LLY

Atle Fund Management AB’s Eli Lilly & Co Position

Does Atle Fund Management AB own Eli Lilly & Co (LLY)? Yes — 39.7K shares worth $27M (+8.67% of its 13F portfolio) as of Q1 2026, up from 31.1K shares the prior filed quarter.

Position Value
$27M
Q1 2026
Shares
39.7K
% of Portfolio
+8.67%
Quarters Held
11
currently held

Position History LLY

Reported value by quarter
Q4 ’22: $122,556Q4 ’22Q4 ’23: $9MQ1 ’24: $16MQ1 ’24Q2 ’24: $25MQ3 ’24: $27MQ3 ’24Q4 ’24: $29MQ1 ’25: $29MQ1 ’25Q2 ’25: $30MQ3 ’25: $3MQ3 ’25Q4 ’25: $33MQ1 ’26: $27MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202639.7K$27M+8.67%
Q4 202531.1K$33M+10.67%
Q3 202537.2K$3M+11.19%
Q2 202538.7K$30M+12.92%
Q1 202534.6K$29M+12.62%
Q4 202437.1K$29M+13.60%
Q3 202430.6K$27M+12.73%
Q2 202427.1K$25M+14.98%
Q1 202420.8K$16M+9.84%
Q4 202315.8K$9M+7.21%
Q4 2022335$122,556+0.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atle Fund Management AB’s full portfolio or all institutional holders of LLY.